Venaxis venaxis.com


Venaxis, prior to 2016, was an in-vitro diagnostic company which had been focused on the clinical development and commercialization of its CE Marked APPY1 Test, the Company's rapid blood-based test for appendicitis. Following failure to obtain FDA clearance for this APPY1 Test, Venaxis is currently evaluating potential strategic alternatives with a focus on enhancing shareholder value using all of the Company's available resources.

Venaxis, prior to 2016, was an in-vitro diagnostic company which had been focused on the clinical development and commercialization of its CE Marked APPY1 Test, the Company's rapid blood-based test for appendicitis. Following failure to obtain FDA cl...Show all

Company (IPO / Went public)

Phone: 303-794-2000

Fax:

1585 South Perry Street

Castle Rock, 80104
Colorado, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Venaxis $3.7M Apr 13, 2002

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Venaxis Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Activity of recombinant equine follicle stimulating hormone Nov 28, 2008 Sep 16, 2014 Patent